BCM
TMO icon

Bancreek Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bancreek Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,050
Closed -$4.5M – 17
2025
Q1 		$4.5M Sell
9,050
-1,002
-10% -$543K 6.74% 8
2024
Q4 		$5.23M Sell
10,052
-5,681
-36% -$3.12M 5.1% 11
2024
Q3 		$9.73M Buy
15,733
+1,359
+9% +$804K 6.14% 4
2024
Q2 		$7.95M Sell
14,374
-4,607
-24% -$2.64M 6.21% 4
2024
Q1 		$11M Sell
18,981
-2,031
-10% -$1.14M 8.22% 3
2023
Q4 		$11.2M Sell
21,012
-443
-2% -$214K 9.47% 3
2023
Q3 		$10.9M Buy
21,455
+5,172
+32% +$2.76M 9.76% 3
2023
Q2 		$8.5M Buy
16,283
+3,730
+30% +$2.01M 6.47% 4
2023
Q1 		$7.24M Buy
12,553
+1,796
+17% +$1.01M 6.09% 4
2022
Q4 		$5.92M Buy
10,757
+432
+4% +$229K 4.8% 4
2022
Q3 		$5.24M Buy
10,325
+1,217
+13% +$681K 4.51% 3
2022
Q2 		$4.95M Buy
9,108
+595
+7% +$328K 3.88% 10
2022
Q1 		$5.03M Buy
8,513
+2,899
+52% +$1.67M 3.29% 19
2021
Q4 		$3.75M Buy
+5,614
New +$3.51M 3.5% 9

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bancreek Capital Management's TMO Position: Q2 2025 in Review

Bancreek Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 9,050 shares — an estimated $4.5M sold.

Bancreek Capital Management first reported a position in TMO in Q4 2021 and held it in 14 quarters. The position peaked at $11.2M in Q4 2023. 2,458 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Bancreek Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Bancreek Capital Management sold 9,050 Thermo Fisher Scientific shares in Q2 2025, an estimated $4.5M.
  • Bancreek Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 14 quarters.
  • Bancreek Capital Management's Thermo Fisher Scientific position peaked at $11.2M in Q4 2023.
  • 2,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Bancreek Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.